title: Effects of peroxisome proliferators on the thymus and spleen of mice.
abstract: The effects of peroxisome proliferators on the immune system of male C57B1/6 mice have been investigated. Significant atrophy of the thymus and spleen was observed in animals treated with potent peroxisome proliferators (e.g. perfluorooctanoic acid (PFOA), di(2-ethylhexyl)phthalate (DEHP), Wy-14643 and nafenopin), whereas the effects of a moderate peroxisome proliferator (i.e. acetylsalicylic acid (ASA)) were relatively weak. The time course of thymic and splenic atrophy caused by PFOA was found to resemble the time course of the increase in liver weight and of peroxisome proliferation. Analysis of the numbers and phenotypes of thymocytes and splenocytes from PFOA-treated mice revealed the following: (i) the numbers of thymocytes and splenocytes were decreased > 90% and about 50%, respectively, by PFOA treatment; (ii) although all populations of thymocytes were decreased, the immature CD4+CD8+ population was decreased most dramatically; (iii) the numbers of both T and B cells in the spleen were decreased by PFOA treatment. Analysis of the cell cycle of thymocytes indicated that the thymic atrophy caused by PFOA in mice results, at least in part, from inhibition of thymocyte proliferation. Interestingly, in vitro exposure to PFOA for up to 24 h did not produce analogous effects in either thymocytes or splenocytes. Thus, the thymic and splenic atrophy caused by PFOA appears to involve an indirect pathway.
authors.affiliation: Department of Biochemistry, Stockholm University, Sweden. Qian@tuborg.biokemi.su.se
authors.forename: Q
authors.initials: Q
authors.lastname: Yang
authors.forename: Y
authors.initials: Y
authors.lastname: Xie
authors.forename: J W
authors.initials: JW
authors.lastname: Depierre
mesh_terms: D000818:Animals; D001241:Aspirin / Q000633:toxicity; D001284:Atrophy; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D002210:Caprylates / Q000633:toxicity; D002453:Cell Cycle / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D004247:DNA / Q000378:metabolism; D004051:Diethylhexyl Phthalate / Q000633:toxicity; D005466:Fluorocarbons / Q000633:toxicity; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009255:Nafenopin / Q000633:toxicity; D020025:Peroxisome Proliferators / Q000633:toxicity*; D011743:Pyrimidines / Q000633:toxicity; D013154:Spleen / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D013950:Thymus Gland / Q000187:drug effects* / Q000276:immunology / Q000473:pathology
chemical_list: D002210:Caprylates; D005466:Fluorocarbons; D020025:Peroxisome Proliferators; D011743:Pyrimidines; D009255:Nafenopin; C006253:pirinixic acid; D004247:DNA; C023036:perfluorooctanoic acid; D004051:Diethylhexyl Phthalate; D001241:Aspirin